Ranitidine Does Not Increase the Risk of Cancer, Study Suggests
A meta-analysis suggests that ranitidine does not pose an increased risk of cancer when compared to other histamine-2 receptor antagonists.
A meta-analysis suggests that ranitidine does not pose an increased risk of cancer when compared to other histamine-2 receptor antagonists.
The US supply of cisplatin is nearly restored, and shortages of carboplatin and methotrexate have been alleviated, the government says.
Cancer patients were more likely to die from the BA.1 and BA.2 omicron variants of SARS-CoV-2 than from wild-type SARS-CoV-2, data suggest.
The burden of administrative tasks required to pay for cancer care is associated with nonadherence to care, a new study suggests.
Lorazepam use may impact progression-free survival and overall survival in patients with a range of cancers, new research suggests.
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
Black and Hispanic patients have a higher risk of death from second primary cancers than White and Asian/Pacific Islander patients, new data suggest.
Cancer patients may be particularly susceptible to transportation-related disruptions in care.
The main cause of the cancer drug shortage, experts agree, is the underlying weakness of the generic drug industry.
Malnutrition may affect 30% to 85% of cancer patients, and it may account for 10% to 20% of deaths in these patients.